Anpac Bio Medical Stock Return On Equity
ANPCDelisted Stock | USD 4.37 0.20 4.38% |
Anpac Bio Medical fundamentals help investors to digest information that contributes to Anpac Bio's financial success or failures. It also enables traders to predict the movement of Anpac Stock. The fundamental analysis module provides a way to measure Anpac Bio's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Anpac Bio stock.
Anpac |
Anpac Bio Medical Company Return On Equity Analysis
Anpac Bio's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current Anpac Bio Return On Equity | -2.43 |
Most of Anpac Bio's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Anpac Bio Medical is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
CompetitionBased on the latest financial disclosure, Anpac Bio Medical has a Return On Equity of -2.4312. This is 89.86% lower than that of the Healthcare sector and 93.33% lower than that of the Biotechnology industry. The return on equity for all United States stocks is notably higher than that of the company.
Anpac Return On Equity Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Anpac Bio's direct or indirect competition against its Return On Equity to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Anpac Bio could also be used in its relative valuation, which is a method of valuing Anpac Bio by comparing valuation metrics of similar companies.Anpac Bio is currently under evaluation in return on equity category among its peers.
Anpac Fundamentals
Return On Equity | -2.43 | |||
Return On Asset | -0.53 | |||
Operating Margin | (8.71) % | |||
Current Valuation | 9.28 M | |||
Shares Outstanding | 6.27 M | |||
Shares Owned By Insiders | 2.15 % | |||
Shares Owned By Institutions | 0.09 % | |||
Number Of Shares Shorted | 44.48 K | |||
Price To Book | 5.67 X | |||
Price To Sales | 0.41 X | |||
Revenue | 12.04 M | |||
Gross Profit | 12.25 M | |||
EBITDA | (78.4 M) | |||
Net Income | (103.6 M) | |||
Cash And Equivalents | 462 K | |||
Cash Per Share | 0.02 X | |||
Total Debt | 19.81 M | |||
Debt To Equity | 1.44 % | |||
Current Ratio | 0.39 X | |||
Book Value Per Share | 10.63 X | |||
Cash Flow From Operations | (55.06 M) | |||
Short Ratio | 2.50 X | |||
Earnings Per Share | (11.45) X | |||
Target Price | 8.0 | |||
Beta | 1.56 | |||
Market Capitalization | 27.41 M | |||
Total Asset | 40.47 M | |||
Retained Earnings | (577.54 M) | |||
Working Capital | (28.58 M) | |||
Current Asset | 23.44 M | |||
Current Liabilities | 68.22 M | |||
Z Score | -26.09 | |||
Net Asset | 40.47 M |
About Anpac Bio Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Anpac Bio Medical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Anpac Bio using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Anpac Bio Medical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.
Other Consideration for investing in Anpac Stock
If you are still planning to invest in Anpac Bio Medical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Anpac Bio's history and understand the potential risks before investing.
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Transaction History View history of all your transactions and understand their impact on performance | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |